Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the depression medication improved the woman's eyebrow hair loss, and a treatment for a skin condition caused by mites was effective.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Using a vibrating device during injections can help reduce pain.

Laser hair removal can be an effective last-resort treatment for men with stubborn Alopecia Areata who want to be uniformly bald.

Lipedematous alopecia involves a thickened scalp and hair loss, with limited effective treatments available.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Stopping imipramine reduced the woman's hair loss.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Alopecia areata treatment varies, with no optimal method established yet.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Dupilumab for skin problems might reactivate hair loss in some patients.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Oral minoxidil can cause inflamed, ingrown hairs in the beard area.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.